VHL
von Hippel-Lindau Syndrome
is a rare genetic disease characterized by the growth of both benign and cancerous tumours in several parts of the body. For 1000 or 1/36,000 in Canada, it is often a life-long battle
von Hippel-Lindau Syndrome
is a rare genetic disease characterized by the growth of both benign and cancerous tumours in several parts of the body. For 1000 or 1/36,000 in Canada, it is often a life-long battle
Patients & Family Members
|
Social-Emotional & Information
|
Blog Weekly
|
VHL Awareness and Hope
October 2018 |
VHL Canada is a small non-profit started by a patient in 2016 that strives to support the lives of people who are coping with VHL in Canada
There's some biomedical VHL research in Canada:
Internationally: (over 40 projects)
- CVHLA to put up $60,000 spread over 2018 and 2019 for Canadian Cancer Research. Our partner, the Cancer Research Society (CRS), has matched this with their own $60,000 ...
- Analysis of VHL patient data intelligence (AI) to better predict cancer (University Health Network, Toronto) ...
- Evidence for genetic anticipation in von Hippel-Lindau syndrome (article authors from Sick Kids, Toronto) ...
Internationally: (over 40 projects)
